Biochemistry of the Eye: Second Edition

Biochemistry of the Eye: Second Edition

Volumn , Issue , 2003, Pages 1-319

  Whikehart, David R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942606868     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7506-7152-1.X5001-2     Document Type: Book

References (395)

1. Berman ER Biochemistry of the eye 1991, Plenum Press, New York.
2. Caprioli J The ciliary epithelia and aqueous humor. Adler's physiology of the eye 1992, Mosby, St. Louis. ed 9. W.M. Hart (Ed.).
3. Daniels F, Alberty RA Physical chemistry 1961, Wiley and Sons, New York.
4. Kim JO, Cotlier E Phospholipid distributions and fatty acid composition of lysophosphatidylcholine and phosphatidylcholine in rabbit aqueous humor, lens and vitreous. Exp Eye Res 1976, 22:569.
5. Lehninger AL, Nelson DL, Cox MM Principles of biochemistry 1993, Worth Publishers, New York. ed 2.
6. Mathews CK, van Holde KE Biochemistry 1990, Benjamin/Cummings, Redwood City, CA.
7. Mayne R, Brewton RG, Z-X Ren Vitreous body and zonular apparatus. Biochemistry of the eye 1997, Chapman and Hall Medical, London. J.J. Harding (Ed.).
8. Sebag J The vitreous. Adler's physiology of the eye 1992, Mosby, St. Louis. W.M. Hart (Ed.).
9. Fundamentals of clinical chemistry 1976, WB Saunders, Philadelphia. N.W. Tietz (Ed.).
10. Tiffany JM Tears and conjunctiva. Biochemistry of the eye 1997, Chapman and Hall Medical, London. J.J. Harding (Ed.).
11. Vaughan D, Asbury T General ophthalmology 1980, Lange, Los Altos, CA. ed 9.
12. Voet D, Voet JG Biochemistry 1995, Wiley and Sons, New York. ed 2.
13. CRC handbook of chemistry and physics 1986, CRC Press, Boca Raton, FL. ed 67. R.C. Weast (Ed.).
14. Aquilina JA, Carver JA, Truscott JW Oxidation products of 3-hydroxykynurenine bind to lens proteins: relevance for nuclear cataract. Exp Eye Res 1997, 64:727-735.
15. Aquilina JA, Carver JA, Truscott RJW Elucidation of a novel polypeptide cross-link involving 3-hydroxykynurenine. Biochem 1999, 38:11455-11464.
16. Berbers GAM, et al. Primary gene products of bovine beta-crystallin and association behavior of its aggregates. Eur J Biochem 1982, 25:495-502.
17. Berman ER Biochemistry of the Eye 1991, Plenum Press, New York.
18. Berta A, Török M Soluble glycoproteins in aqueous tears. The Preocular Tear Film 1986, Dry Eye Institute, Lubbock, TX. F.J. Holly (Ed.).
19. Bettelheim FA, Chylack LT Light scattering of whole excised human cataractous lenses. Relationships between different light scattering parameters. Exp Eye Res 1985, 41:19-30.
20. Birk D, Linsenmayer TF Collagen fibril assembly, deposition, and organization into tissue-specific matrices. Extracellular Matrix Assembly and Structure 1994, Academic Press, San Diego. P.D. Yurchenko, D.E. Birk, R.P. Mecham (Eds.).
21. Bloemendal H The vertebrate eye lens. Science 1977, 197:127-138.
22. Borcherding MS, et al. Proteoglycans and collagen fibre organization in human corneo-scleral tissue. Exp Eye Res 1975, 21:59-70.
23. Bours J, Hockwin O Artunterschiede bei Linsenproteinen nach Trennung mit Isolekktrofukussiering auf Polyactylamid-Dunnschichplatten. Berl Munch Tieraerztl Wochenshr 1976, 89:417-422.
24. Brewton RG, Wright DW, Mayne R Structural and functional comparison of type IX collagen-proteoglycan from chicken cartilage and vitreous humor. J Biol Chem 1991, 266:4752-4757.
25. Bridges C Biochemistry of vision. Biochemistry of the Eye 1970, Academic Press, New York. C. Graymore (Ed.).
26. Brinker JM, et al. Immunochemical characterization of type IV procolla-gen from anterior lens capsule. Collagen and Related Res 1985, 5:233-244.
27. Chao C-CW, Butala SM, Herp A Studies on the isolation and composition of human ocular mucin. Exp Eye Res 1988, 47:185-196.
28. Chen YC, et al. Molecular evidence for the involvement of alpha crys-tallin in the colouration/crosslinking of crystallins in age-related nuclear cataract. Exp Eye Res 1997, 65:835-840.
29. Chiesa R, McDermott MJ, Spector A Defferential synthesis and phos-phorylation of the alpha-crystallin A and B chains during bovine lens fiber cell differentiation. Curr Eye Res 1989, 8:151-158.
30. Dillon J UV-B as a pro-aging and pro-cataract factor. Doc Ophthalmol 1994, 88:339-344.
31. Eghbali-Webb M Molecular biology of collagen matrix in the heart 1995, R G Landes, Austin, TX.
32. Farnsworth P, et al. Predicted 3-D structure of alpha-crystallin subunits using molecular dynamics provides a working model, [ARVO Abstract]. Invest Ophthalmol Vis Sci 1993, 34. Abstract nr 1412.
33. Garcia-Castineiras S, Dillon J, Spector A Non-tryptophan fluorescence associated with human lens protein; apparent complexity and isolation of bityrosine and anthranilic acid. Exp Eye Res 1978, 26:461-476.
34. Garner MH, Spector A Selective oxidation of cysteine and methionine in normal and senile cataractous lenses. Proc Natl Acad Sci USA 1980, 77:1274-1277.
35. Gipson IK, Spurr-Mauchaud JJ, Tisdale AS Anchoring fibrils form a complex network in human and rabbit cornea. Invest Ophthalmol Vis Sci 1987, 28:212-220.
36. Gordon WC, Bazan NG Retina. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
37. Harding JJ Changes in lens proteins in cataract. Molecular and cellular biology of the eye 1981, John Wiley and Sons, New York. H. Bloemendal (Ed.).
38. Harding JJ Cataract: biochemistry, epidemiology and pharmacology 1991, Chapman and Hall, London.
39. Harding JJ Lens. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
40. Harding JJ, Carbbe MJC The lens: Development, proteins, metabolism and cataract. The eye 1984, Academic Press, Orlando, FL. H. Davson (Ed.).
41. Hoenders HJ, Bloemendal H Aging of lens proteins. Molecular and cellular biology of the eye lens 1981, John Wiley and Sons, New York. H. Bloemendal (Ed.).
42. Horwitz J The function of alpha-crystallin. Invest Ophthalmol Vis Sci 1993, 34:10-22.
43. Hulmes DJ The collagen superfamily-diverse structures and assemblies. Essays Biochem 1992, 27:49-67.
44. Jakus M Ocular fine structure, selected electron micrographs 1964, Little, Brown, Boston.
45. Kapoor R, Bornstein P, Sage H Type VIII collagen from bovine Descement's membrane: Structural characterization of a triple-helical domain. Biochemistry 1986, 25:3930-3937.
46. Kenyon KR Recurrent corneal erosion: Pathogenesis and therapy. Int Ophthalmol Clin 1979, 19:169-195.
47. Lampi KJ, et al. Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res 1998, 67:31-43.
48. Lampi KJ, et al. Sequence analysis of betaA3, betaB3, and beta A4 crystallins completes the identification of the major proteins in young human lens. J Biol Chem 1997, 272:2268-2275.
49. Lerman S, Borkman R Spectroscopic evaluation and classification of the normal, aging, and cataractous lens. Ophthalmic Res 1976, 8:335-353.
50. Mayne R, Brewton RG, Ren Z Vitreous body and zonular apparatus. Biochemistry of the eye 1997, Chapman and Hall, London, X. J.J. Harding (Ed.).
51. Meites L, Thomas HC Advanced analytical chemistry 1958, McGraw-Hill, New York.
52. Miller EJ, Gay S Collagen structure and function. Wound healing, biochemical and clinical aspects 1992, W B Saunders, Philadelphia. I.K. Cohen, R.F. Dieglemann, W.J. Lindblad (Eds.).
53. Molday RS Photoreceptor membrane proteins, phototransduction, and retinal degenerative diseases. Invest Ophthalmol Vis Sci 1998, 39:2493-2513.
54. Nathans J The evolution and physiology of human color vision: insights from molecular genetic studies of visual pigments. Neuron 1999, 24:299-312.
55. Newsome DA, Gross J, Hassell JR Human corneal stroma contains three distinctive collagens. Invest Ophthalmol Vis Sci 1982, 22:376-381.
56. Pirie A Formation of N'-formylkynurenine in proteins from lens and other sources by exposure to sunlight. Biochem J 1971, 128:1365-1367.
57. Pirie A Fluoresence of N'-formylkynurenine and of proteins exposed to sunlight. Biochem J 1972, 128:1365-1367.
58. Sebag J, Balazs EA Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 1989, 30:1867-1871.
59. Shichi H Biochemistry of vision 1983, Academic Press, New York.
60. Spector A The search for a solution to senile cataracts. Invest Ophthalmol Vis Sci 1984, 25:130-146.
61. Srivastava OP, Srivastava K Degradation of yD- and ys-Crystallins in human lens. Biochem Biophys Res Communications 1998, 253:288-294.
62. Srivastava OP, Srivastava K, Harrington V Age-related degradation of β/a3/A1-crystallin in human lenses. Biochem Biophys Res Communications 1999, 258:632-638.
63. Stryer L Biochemistry 1988, Academic Press, Orlando, FL.
64. Summers LJ, et al. A computer graphics model of frog Γ-crystallin based on the three-dimensional structure of calf Γ-II crystallin. FEBS Letters 1986, 208:11-16.
65. Swann DA, Sotman SS The chemical composition of bovine vitreous-humour collagen fibres. Biochem J 1980, 185:545-554.
66. Takemoto L Increased deamidation of asparagine-101 from alpha-A crystallin in the high molecuar weight aggregate of the normal human lens. Exp Eye Res 1999, 68:641-645.
67. Tiffany JM Tears and conjunctiva. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
68. Truscott RJW, Faull K, Augusteyn RC The identification of anthranilic acid in proteolytic digests of cataractous lens proteins. Ophthalmic Res 1977, 9:263-268.
69. van der Rest M, Garrone R Collagen family of proteins. FASEB Journal 1991, 5:2814-2823.
70. van Heyningen R The glucoside of 3-hydroxykynurenine and other fluorescent compounds in the human lens. The human lens in relation to cataract 19 1973, Elsevier, Amsterdam, The Netherlands.
71. Voet D, Voet JG Biochemistry 1995, John Wiley and Sons, New York.
72. Wald G The molecular basis of visual excitation. Nature 1968, 219:800-807.
73. Wistow GJ, Piatigorsky J Lens crystallins: The evaluation and expression of proteins for a highly specialized tissue. Ann Rev Biochem 1988, 57:479-504.
74. Wood MW, Truscott RJW UV filters in human lenses: tryptophan catabolism. Exp Eye Res 1993, 56:317-325.
75. Bhatnager A, et al. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors. Biochem Pharm 1990, 39:1115-1124.
76. Copeland R Enzymes. A practical introduction to structure, mechanism, and data analysis 2000, John Wiley and Sons, New York.
77. Flynn T Aldose and aldehyde reductase in animal tissues. Metabolism 1986, 35(Suppl 1):105-108.
78. Frank R Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?. Arch Ophthalmol 1990, 108:1229-1231.
79. Gillette T, Greiner J, Allansmith M Immunohistochemical localization of human tear lysozyme. Arch Ophthalmol 1981, 99:298-300.
80. Guggenheim J, McBrien N Form-deprivation myopia induces activation of scleral matrix metalloproteinase-2 in tree shrew. Investigative Ophthalmol Vis Science 1996, 37:1380-1395.
81. Harding JJ Can drugs or micronutrients prevent cataract?. Drugs Aging 2001, 18:473-486.
82. Hogan M, Alvarado J, Weddell J Histology of the human eye 1971, WB Saunders Co, Philadelphia.
83. Jacq C, et al. Lactic dehydrogenase isozymes in the ocular tissues and liquids. Ophthalmologica Vasel 1982, 184:174-178.
84. Kador P, Kinoshita J, Sharpless N The aldose reductase inhibitor site. Metabolism 1986, 35(Suppl 1):109-113.
85. Kinoshita J Cataracts in galactosemia. Invest Ophthalmol 1965, 5:786-789.
86. Kinoshita J Mechanisms initiating cataract formation. Invest Ophthalmol 1974, 13:713-724.
87. Klaeger AJ, et al. Clinical application of a homogeneous colorimetric assay for tear lysozyme. Ocular Immunology and Inflammation 1999, 7:7-15.
88. Knauper V, Murphy G Membrane-type matrix metalloproteinases and cell surface-associated activation cascades for matrix metalloproteinases. Matrix metalloproteinases 1998, Academic Press, San Diego, CA. W. Parks, R. Mecham (Eds.).
89. Li J, et al. Molecular identification and immunolocalization of the water channel protein aquaporin 1 in CBCECs. Invest Ophthalmol Vis Science 1999, 40:1288-1292.
90. S-L Li, et al. Cancer associated lactate dehydrogenase is a tyrosyl-phosphorylated form of human LDH-M, a skeletal muscle isozyme. Cancer Invest 1988, 6:93-101.
91. Mathews C, von Holde K Biochemistry 1990, Benjamin/Cummings, Redwood City, CA.
92. Nigase H Stromelysins 1 and 2. Matrix metalloproteinases 1998, Academic Press, San Diego, CA. W. Parks, R. Mecham (Eds.).
93. Palmer T Understanding Enzymes 1981, John Wiley and Sons, New York.
94. Paoli M, et al. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains. Nature Struc Biol 1999, 6:926-931.
95. Parrish C, Chandler J Corneal trauma. The Cornea 1998, Butterworth-Heinemann, Boston. H. Kaufman, B. Barron, M. McDonald (Eds.).
96. Paterson C, et al. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits. Invest Ophthalmol Vis Science 1994, 35:677-684.
97. Rada J, et al. Gelatinase A and TIMP-2 expression in the fibrous sclera of myopic and recovering chick eyes. Invest Ophthalmol Vis Science 1999, 40:3091-3099.
98. Rittner H, et al. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 1999, 103:1007-1013.
99. Robinson B, et al. Aldose and aldehyde reductases form human kidney, cortex, and medulla. Biochim Biopys Acta 1993, 1203:260-266.
100. Saavedra R, Cordoba C, Anderson G LDHk in the retina of diverse vertebrate species: a possible link to the Warburg effect. Exp Eye Res 1985, 41:365-370.
101. Selsted M, Martinez R Isolation and purification of bacteriocides from human tears. Exp Eye Res 1982, 34:305-318.
102. Sen D, Sarin G Immunoassay of human tear film lysozyme. Am J Ophthalmol 1980, 90:715-718.
103. Stryer L Biochemistry 1988, WH Freeman and Co, New York.
104. Van Bijsterveld O Standardization of the lysozyme test for a commercially available medium. Arch Ophthalmol 1974, 432-434.
105. Van Bijsterveld O, Westers J Therapie bei Keratolon-junktivitis sicca. Klin Monatsbl Augenheilkd 1980, 177:52-57.
106. Van Heyinigen R Formation of polyols by the lens of the rat with 'sugar' cataract. Nature 1959, 184:194-195.
107. Warburg O, Posener K, Newgalein E Über den Stoffwechsel de Carcinonzelle. Biochem Z 1924, 152:308-344.
108. Wentworth J, Paterson C, Gray R Effect of metalloproteinase inhibitor on established corneal ulcers after an alkali burn. Invest Ophthalmol Vis Science 1992, 33:2174-2179.
109. +ATPase in plasma membranes from corneal endothelium: fresh tissue vs. tissue culture. Curr Eye Res 1987, 6:709-717.
110. Woessner J The matrix metalloproteinase family. Matrix metalloproteinases 1998, Academic Press, San Diego, CA. W. Parks, R. Mecham (Eds.).
111. Apple DJ, et al. Diabetes and eye disease: histopathologic correlation. Diabetes and its ocular complications 1988, WB Saunders, Philadelphia.
112. Balazs EA The antino sugars 1965, Academic Press, London. E.A. Balazs, R.W. Jeanloz (Eds.).
113. Benson WE, Brown GC, Tasman W Diabetes and its ocular complications 1988, WB Saunders, Philadelphia.
114. Berman ER Biochemistry of the eye 1991, Plenum Press, New York.
115. Bishop PN, McLeod D, Reardon A Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel. Invest Ophthalmol Vis Science 1999, 40:2173-2178.
116. Brewton RG, Mayne R Mammalian vitreous humor contains networks of hyaluronan molecules: electron microscopic analysis using the hyaluronan-binding region (G1) of aggrecan and link protein. Exper Cell Res 1992, 198:237-249.
117. Bridger WA, Henderson JF Cell ATP 1983, J. Wiley and Sons, New York.
118. Bron AJ, et al. The lens in diabetes. Eye 1993, 7(PT 2):260-275.
119. Brownlee M Advanced glycation end products in diabetic complications. Curr Opin Endocrinol 1996, 3:291-297.
120. Busted N, Olsen T, Schmitz O Clinical observations on the corneal thickness and the corneal endothelium in diabetes mellitus. Br J Ophthalmol 1981, 65:687-690.
121. Caraway WT, Watts NB Carbohydrates. Textbook of clinical chemistry 1986, WB Saunders, Philadelphia. W.W. Tietz (Ed.).
122. Chakrabarti S, et al. Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve. Dibetologia 1987, 30:244-251.
123. Cohen MP Diabetes and protein glycosylation 1986, Springer-Verlag, New York.
124. Czech MP, Corvera S Signaling mechanisms that regulate glucose transport. J Biol Chem 1999, 274:1865-1868.
125. Elsas LJ, et al. A common mutation associated with the Duarte galactosemia allele. Am J Hum Genet 1994, 54:1030-1036.
126. Fisher LW, Termine JD, Young MF Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several non-connective proteins in a variety of species. J Biol Chem 1989, 264:4571-4576.
127. Grayson M Diseases of the cornea 1979, CV Mosby, St. Louis.
128. Hamano H, Kaufman HE The physiology of the cornea and contact lens applications 1987, Churchill Livingstone, New York.
129. Hecht SM Bioorganic chemistry: carbohydrates 1999, Oxford University Press, New York.
130. Herse P Corneal hydration control in normal and alloxan-induced diabetic rabbits. Invest Ophthalmol Vis Sci 1990, 31:2205-2213.
131. Ishida N, et al. Corneal nerve alterations in diabetes mellitus. Arch Ophthalmol 1984, 102:1380-1384.
132. Jost CJ, et al. Cell free translation and characterization of corneal keratan sulfate proteoglycan core proteins. J Biol Chem 1991, 266:13336-13341.
133. Kador PF, et al. Relative importance of aldose reductase versus non-enzymatic glycosylation on sugar cataract formation in diabetic rats. J Ocular Pharm Therapeut 2000, 16:149-160.
134. Kaji Y, et al. Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Science 2000, 41:362-368.
135. Kenyon K, et al. Corneal basement membrane abnormality in diabetes mellitus. Invest Ophthalmol Vis Sci 1978, 17(Suppl.):245.
136. Kern TS, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Science 2000, 41:3972-3978.
137. King GL The role of protein kinase C activation in the development of vascular disease in diabetes. Curr Opin Endocrinol 1996, 3:285-290.
138. Kinoshita J, et al. Factors affecting the formation of sugar alcohols in the ocular lens. Biochem Biophys Acta 1963, 74:350-351.
139. Kinoshita JH Mechanism initiating cataract formation. Invest Ophthalmol 1974, 13:713-724.
140. Kinoshita JH A thirty year journey in the polyol pathway. Exp Eye Res 1990, 50:567-573.
141. Klyce SD Stromal lactate accumulation can account for corneal edema osmotically following epithelial hypoxia in the rabbit. J Physiol 1981, 321:49-64.
142. Koschinsky T Effect of insulin on the blood vessel wall. Pediatric and adolescent endocrinology 1988, Korger, Basel. B. Weber (Ed.).
143. Kulkarni RN, et al. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96:329-339.
144. Lass JH, et al. A morphological and fluorometric analysis of the corneal endothelium in type I diabetes mellitus and cystic flbrosis. Am J Ophthalmol 1985, 100:783-785.
145. Lodish H, et al. Molecular cell biology 2000, WH Freeman and Co, NY. ed 4.
146. Martin DW, et al. Harper's review of biochemistry 1985, Lange Medical, Los Altos, CA. ed 20.
147. Mathews CK, van Holde KE Biochemistry 1990, Benjamin/Cummings, Redwood City, CA.
148. Maurice DM The structure and transparency of the cornea. J Physiol 1957, 136:263-286.
149. McCartney MD, Wood TO, McLaughlin BJ ATPase pump site density in human dysfunctional corneal endothelium. Invest Ophthalmol Vis Sci 1987, 28:1955-1962.
150. McGilvey RW, Goldstein GW Biochemistry, a functional approach 1983, WB Saunders, Philadelphia.
151. Midura RJ, et al. Proteoglycan biosynthesis by human corneas from patients with types 1 and 2 macular dystrophy. J Biol Chem 1990, 265:15947-15955.
152. Mizutani Y, et al. The effect of anoxia on the human cornea. Acta Soc Ophthalmol Japan 1983, 87:644-649.
153. Morita J, et al. Sequence specific damage of DNA by reducing sugars. Nucleic Acids Res 1985, 13:449-458.
154. Neuenschwander H, et al. Endothelial changes in galactose-fed dogs. Current Eye Res 1995, 14:319-322.
155. Neufeld EF, Muenzer J The mucopolysaccharidoses (Vol. II). The metabolic and molecular bases of inherited disease 1995, McGraw-Hill, NY. C.R. Scriver (Ed.).
156. Ohguro N, et al. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients. Br J Ophthalmol 1995, 79:1074-1077.
157. Olitsky SE, Nelson LB Common ophthamologic concerns in infants and children. Ped Clin North America 1998, 45:993-1012.
158. Olsen T, Busted N Corneal thickness in eyes with diabetic and nondiabetic neovascularization. Br J Ophthalmol 1981, 65:687-790.
159. J-Y Park, et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 2000, 49:1239-1248.
160. Pessin JE, Saltiel AR Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000, 106:165-170.
161. Qian M, Ealon JW Glycocholates and the etiology of diabetic peripheral neuropathy. Free Radical Biology and Medicine 2000, 28:652-656.
162. Robison WG, Houlder N, Kinoshita JH The role of lens epithelium in sugar cataract formation. Exp Eye Res 1990, 50:641-646.
163. Roehrig KL Carbohydrate biochemistry and metabolism 1984, AVI Publishing, Westport, CT.
164. Rudnicka AR, Birch J Diabetic eye disease 2000, Butterworth-Heinemann, Oxford.
165. Sanchez-Thorin JC The cornea in diabetes mellitus. International ophthalmology clinics 1998, 38. Lippincott-Raven, Philadelphia. J.C. Sanchez-Thorin (Ed.).
166. Schleicher ED, et al. Chemistry and pathobiology of advanced glycation end products. Advanced glycation end products in nephrology 2001, Karger, Basel. A. D'Angelo, S. Favaro, G. Gambaro (Eds.).
167. Schultz RO, et al. Corneal endothelial changes in type I and II diabetes mellitus. Am J Ophthalmol 1984, 98:401-410.
168. Segal S, Berry GT Disorders of galactose metabolism. The metabolic and molecular bases of inherited diseases 1995, McGraw-Hill, New York. ed 7. C.H. Scriver (Ed.).
169. Stryer L Biochemistry 1988, WH Freeman, New York.
170. Sugar J Metabolic diseases of the cornea. The cornea 1998, Butterworth-Heinemann, Boston. ed 2. H.E. Kaufman, B.A. Barron, M.B. McDonald (Eds.).
171. Swarbrick HA, Holden BA Extended wear lenses. Contact lenses 1997, Butterworth-Heinemann, Oxford. ed 4. A.J. Phillips, L. Speedwell, J. Stone (Eds.).
172. Tomlinson DR Aldose reductase and tissue damage in diabetes. Diabetic retinopathy 2000, Martin Dunotz Ltd, London. O.P. van Bijsterveld (Ed.).
173. Van Bijsterveld OP, Klaassen-Broekema N Extraretinal ocular pathology in diabetes. Diabetic retinopathy 2000, Martin Dunitz Ltd, London. O.P. van Bijsterveld (Ed.).
174. Varma SD, Mizuno A, Kinoshita JH Diabetic cataracts and flavonoids. Science 1977, 195:205-206.
175. Voet D, Voet JG Biochemistry 1995, John Wiley and Sons, New York. ed 2.
176. Waggoner DD, Buist NR, Donnell GN Long-term prognosis in galac-tosemia: results of a survey of 350 cases. J Inherit Metab Dis 1990, 13:802-818.
177. Weiss MF, et al. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney International 2000, 57:2571-2585.
178. Whikehart DR Glutathione peroxidase activity in the bovine corneal endothelium. A comparison with its activity in the corneal epithelium and whole lens. Ophthalmic Res 1978, 10:187-193.
179. Whikehart DR, et al. Alteration of ATPase activity and duplex DNA in corneal cells grown in high glucose media. Cornea 1993, 12:295-298.
180. Wildman REC, Medeiros DM Advanced human nutrition 2000, CRC Press, New York.
181. Williams G, Pickup JC Handbook of diabetes 1999, Blackwell Science, Oxford. ed 2.
182. Anderson RE Chemistry of photoreceptor outer segments. Biochemistry of the eye 1983, American Academy of Ophthalmology, San Francisco.
183. Brady RO Sphingolipidoses and other lipid metabolic disorders. Basic neurochemistry 1981, Little, Brown and Co, Boston. ed 3. G.J. Siegel (Ed.).
184. Broekhuyse RM, Daemen FJM The eye. Lipid metabolism in mammals 1977, Pleunm Press, New York. F. Snyder (Ed.).
185. Chader GJ Retinoids in ocular tissues: binding proteins, transport, and mechanism of action. Cell biology of the eye 1982, Academic Press, New York. D.S. McDevitt (Ed.).
186. H-B Chen, et al. Structure and composition of rat precorneal tear film. Invest Ophthalmol Vis Science 1997, 38:381-387.
187. Danielli JF, Davson H A contribution to the theory of permeability of thin films. J Cell Com Physiol 1935, 5:495-507.
188. Davson H Physiology of the eye 1990, Pergamon Press, New York. ed 5.
189. Gordon WC, Bazan NG Retina. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
190. Grayson M Diseases of the cornea 1979, CV Mosby Co, St. Louis.
191. 2 gangliosidoses. The metabolic and molecular bases of inherited disease 1995, McGraw-Hill, New York. ed 7. C.R. Scriver (Ed.).
192. Hathcock JN, et al. Evaluation of vitamin A toxicity. Am J Clin Nutr 1990, 52:183-202.
193. Holly F, Lemp MA Tear physiology and dry eyes. Surv Ophthalmology 1977, 22:69-87.
194. Hollyfield JG, et al. Synthesis and secretion of interstitial retinol binding protein by the human retina. Invest Ophthalmol Vis Sci 1985, 26:58-67.
195. Houslay MD, Stanley KK Dynamics of biological membranes 1982, J Wiley and Sons, New York.
196. King-Smith PE, et al. The thickness of the human precorneal tear film: evidence from reflection spectra. Invest Ophthalmol Vis Science 2000, 41:3348-3359.
197. Lehninger AL Principles of biochemistry 1982, Worth Publishers, New York.
198. Lodish H, et al. Molecular cell biology 2000, WH Freeman, New York.
199. Mathews CK, van Holde KE Biochemistry 1990, Benjamin/Cummings, Redwood City, CA.
200. Mayes PA Lipids. Harper's review of biochemistry 1985, Lange Medical, Los Altos, CA. ed 20. D.W. Martin (Ed.).
201. Milder B The lacrimal apparatus. Adler's physiology of the eye 1987, CV Mosby, St. Louis. R.E. Moses, W.M. Hart (Eds.).
202. McCulley JP, Dougherty JM Meibomian lipids in chronic blepharitis. The precorneal tear film in health, disease, and contact lens wear 1986, Dry Eye Institute, Lubbock, TX.
203. Recommended Dietary Allowances 1989, National Research Council, National Academy Press, Washington, DC. ed 10.
204. Nicolaides N Recent findings on the chemical composition of the lipids of steer and human meibomian glands. The precorneal tear film in health, disease, and contact lens wear 1986, Dry Eye Institute, Lubbock, TX.
205. Nicolaides N, et al. The lipids of chalazia. Invest Ophthalmol Vis Sci 1988, 29:482-486.
206. Nicolaides N, et al. Meibomian gland dysfunction. III Meibomian gland lipids. Invest Ophthalmol Vis Sci 1989, 30:946-951.
207. +/glucose cotransporter. J Biol Chem 1997, 272:20324-20327.
208. Pflugfelder SC, et al. Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest Ophthalmol Vis Science 2000, 41:1316-1326.
209. Singer SJ, Nicolson GL The fluid mosaic model of the structure of cell membranes. Science. 1972, 175:720-731.
210. Skelton WP, Skelton NK Deficiency of vitamins A, B and C. Postgrad Med 1990, 87(No. 4):273-310.
211. Stryer L Biochemistry 1988, WH Freeman and Co, New York.
212. Sugar J Metabolic disorders of the cornea. The cornea 1998, Butterworth-Heinemann, Boston. ed 2. H.E. Kaufmann, B.A. Barron, M.B. McDonald (Eds.).
213. Townsend WM Congenital anomalies of the cornea. The cornea 1998, Butterworth-Heinemann, Boston. ed 2. H.E. Kaufmann, B.A. Barron, M.B. McDonald (Eds.).
214. Voet D, Voet JG Biochemistry 1995, John Wiley and Sons, New York. ed 2.
215. Yeagle P The structure of biological membranes 1991, CRC Press, Boca Raton, FL.
216. Zingg JM, Ricciarelli R, Azzi A Scavenger receptor regulation and atherosclerosis. Biofactors 2000, 11:189-200. Recommended Dietary Allowances (9th ed). Food and Nutrition Board, National Research Council, National Academy of Sciences, 1980.
217. Abdel-Latif AA Iris-ciliary body, aqueous humor and trabecular mesh-work. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
218. The ocular effects of prostaglandins and other eicosanoids 1989, Alan R. Liss, NY. L.Z. Bito, J. Stjernschantz (Eds.).
219. 2α-1-isopropyl ester. Exp Eye Res 1987, 44:217-226.
220. Burch HA, et al. Ophthalmopathy. Werner and Ingbar's The thyroid. A fundamental and clinical text 2000, Lippincott, Williams and Wilkins, Philadelphia. ed 8. L.E. Braverman, R.D. Utiger (Eds.).
221. Char DH Thyroid. Eye disease 1990, Livingstone, NY. ed 2.
222. Clark AF, et al. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci 2001, 42:1769-1780.
223. Dickerson JE, Dotzel E, Clark AF Steroid-induced cataracts: new perspectives from in vitro and lens culture studies. Exp Eye Res 1997, 65:507-516.
224. Dizhoor AM, et al. Cloning, sequencing, and expression of a 24-kDa Ca (2+) binding protein activating photoreceptor guanylyl cyclase. J Biol Chem 1995, 270:25200-25206.
225. Edelhauser HF, et al. Swelling in the isolated perfused cornea induced by 12(R)hydroxyeicosatetraenoic acid. Invest Ophthalmol Vis Sci 1993, 34:2953-2961.
226. Fain GL, et al. Adaptation in vertebrate photoreceptors. Physiolog Rev 2001, 81:117-151.
227. Fleischhauer JC, et al. NO/cGMP pathway activation and membrane potential depolarization in pig ciliary epithelium:. Invest Ophthalmol Vis Science 2000, 41:1759-1763.
228. Furchgott RF Jothianandan: Endothelium-dependent and independent vasodilation involving cGMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991, 28:52-61.
229. Gordon WC, Bazan NG Retina. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
230. Graves RJ Newly observed affection of the thyroid gland in females, London. Med Surg J 1835, 7:516-520.
231. Harding JJ Lens. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
232. S-C Hsu, Molday RS Interaction of calmodulin with the cyclic GMP-gated channel of rod photoreceptor cells. J Biol Chem 1994, 269:29765-29770.
233. Jaanus SD Anti-inflammatory drugs. Clinical ocular pharmacology 1989, Butterworths, Boston. ed 2. J.D. Bartlett, S.D. Jaanus (Eds.).
234. Kacsoh B Endocrine physiology 2000, McGraw-Hill, New York.
235. 2 on EFG-induced map kinase activity and rabbit corneal epithelial proliferation. Invest Opthalmol Vis Science 2000, 41:2164-2169.
236. + channels in the mouse retina. Vis Neuroscience 1995, 12:1177-1190.
237. Lodish H, et al. Molecular cell biology 1999, WH Freeman and Co, New York. ed 4.
238. Mathews CK, van Holde KE Biochemistry 1990, Benjamin/Cummings Publishing, Redwood City, CA.
239. Mayes PA Metabolism of lipids: I. Fatty acids. Harper's review of biochemistry 1985, Lange, Los Altos, CA. ed 20. D.W. Martin (Ed.).
240. Mayman CI, Miller D, Tijerina ML In vitro production of steroid cataract in bovine lens: Part II, measurement of sodium-potassium adenosine triphosphatase activity. Acta Ophthalmol 1979, 57:1107-1117.
241. Mieyal PA, et al. The effect of hypoxia on endogenous corneal eicosanoids. Invest Ophthalmol Vis Sci 2000, 41:2170-2176.
242. Mittag TW Signal transduction systems for prostaglandins in the iris and ciliary body. The ocular effects of prostaglandins and other eicosanoids 1989, Alan R. Liss, Inc, NY.
243. McGilvery RW, Goldstein GW Biochemistry: A functional approach 1983, WB Saunders, Philadelphia.
244. Molday RS Photoreceptor membrane proteins, phototransduction, and retinal degenerative diseases, Invest. Ophthamol Vis Science 1998, 39:2493-2513.
245. Ohtsuka K, Hashimoto M Serum levels of soluble Fas in patients with Graves' ophthalmopathy. Br J Ophthalmol 2000, 84:103-106.
246. Ogueta SB, et al. Estrogen receptor in the human eye: influence of gender and age on gene expression. Investigative Ophthalmol Vis Sci 1999, 40:1906-1911.
247. Parry CH Enlargement of thyroid gland in connection with enlargement or palpitation of the heart. Collections from unpublished writings of late Caleb Hillier Parry 1825, 2. Underwoods, London.
248. Pinto LH, Klumpp DJ Localization of potassium channels in the retina. Progr Retinal and Eye Res 1998, 17:207-230.
249. Piomelli D Arachidonic acid in cell signaling 1996, Chapman and Hall, NY.
250. 2+ -binding proteins in the retina. Trends Neurosci 1996, 19:547-554.
251. Polansky JR, Fauss DJ, Zimmerman CC Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells. Eye 2000, 14:503-514.
252. Rail TW The methylxanthines. The Pharmacological Basis of Therapeutics 1985, MacMillan, New York. A.G. Gilman, L.S. Goodman, T.W. Rall, F. Murad (Eds.).
253. Scherer WJ A retrospective review of nonresponders to latanoprost. J of Pharm Ther 2002, 18:287-291.
254. Soni PS Effects of oral contraceptive steroids on the thickness of human cornea. Am. J Optom Physiol Optics 1980, 57:825-834.
255. 2α-isopropyl ester to latanoprost: a review of the development of xalatan, Invest. Ophthalmol Vis Sci 2001, 42:1134-1145.
256. Stokes J, et al. Distribution of glucocorticoid and mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenase in human and rat ocular lenses. Investigative Ophthalmol and Vis Sci 2000, 41:1622-1638.
257. Textbook of clinical chemistry 1986, WB Saunders, Philadelphia, 1820 and 1842. N.W. Tietz (Ed.).
258. Urban RC, Cottier E Corticosteroid-induced cataracts. Surv Ophthalmol 1986, 31:102-110.
259. Utiger RD Hyperthyroidism. The thyroid 1987, Elsevier, NY. W.L. Green (Ed.).
260. Vassart G, Dumont JE, Refetoff S Thyroid disorders. The Metabolic and Molecular Bases of Inherited Disease 1996, McGraw-Hill, New York. ed. 7.
261. Verrey F, Kraehenbuhl JP, Rossier BC Aldosterone induces a rapid increase in the rate of Na, K-ATPase gene transcription in cultured kidney cells. Molecular Endocrine 1989, 3:1369-1376.
262. 1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells. Invest Ophthalmol Vis Sci 1992, 33:1870-1878.
263. Prostaglandins in clinical practice 1989, Raven Press, NY. W.O. Watkins, M.B. Peterson, J.R. Fletcher (Eds.).
264. Weintraub BD Molecular endocrinology. Basic concepts and clinical correlations 1985, Raven Press, NY.
265. Zagrod M, Whikehart DR Cyclic nucleotides in anatomical subdivisions of the bovine lens. Curr Eye Res 1981, 1:49-52.
266. Alberts B, et al. Molecular Biology of the Cell. 2nd edition. Chapter 9: The cell nucleus 1989, Garland Publishing, New York.
267. Alberts B, et al. Molecular Biology of the Cell. 2nd edition. Chapter 21: Cancer 1989, Garland Publishing, New York.
268. Alberts B, et al. Molecular Biology of the Cell. 2nd edition. Chapter 8: Intracellular sorting and the maintenance of cellular compartments 1989, Garland Publishing, New York.
269. nd edition. Chapter 6: Basic genetic mechanisms 1994, Garland Publishing, New York.
270. Ardell MD, et al. Genomic organization of the human rod photoreceptor cGMP-gated cation channel β-subunit gene. Gene 2000, 245:311-318.
271. Balasubramanian D Ultraviolet radiation and cataract. J Ocular Pharm Therap 2000, 16:285-297.
272. Berry V, et al. A locus for autosomal dominant anterior polar cataract on chromosome 17p. Hum Mol Genet 1996, 5:415-419.
273. Blackburn EH, Greider CW Telomeres 1995, Cold Spring Harbor Laboratory Press, Plainview, NY.
274. Boussif O, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995, 92:7297-7301.
275. Burns RP A double-blind study of IDU in human herpes simplex keratitis. Arch Ophthalmol 1963, 70:381-384.
276. Campbell J, Stock G A vision for practical human germline engineering. Engineering the Human Germline 2000, Oxford University Press, New York. G. Stock, J. Campbell (Eds.).
277. Carper D, et al. Deficiency of functional messenger RNA for a develop-mentally regulated β-crystallin polypeptide in a hereditary cataract. Science 1982, 217:463-464.
278. Colville CA, Molday RS Primary structure and expression of the human beta-subunit and related proteins of the rod photoreceptor cGMP-gated channel. J Biol Chem 1996, 271:32968-32974.
279. Crick FHC On protein synthesis. Symp Soc Exp Bio 1958, 12:138-162.
280. Daniels F, Alberty RA Physical Chemistry 1961, Wiley and Sons, New York. 2nd ed.
281. Dryja TP, et al. Mutations in the gene encoding the alpha subunit of the rod cGMP-gated channel in autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci USA 1995, 92:10177-10181.
282. Duncan MK, et al. Truncated forms of Pax-6 disrupt lens morphology in transgenic mice. Invest Ophthalmol Vis Science 2000, 41:464-473.
283. Elion GB The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother 1983, 12(Suppl B):9-17.
284. Fradkin LG, Ropp JD, Warner JF Gene-based therapeutics. Principles of Tissue Engineering 2000, Academic Press, San Diego. 2 nd ed.. R.P. Lanza, R. Langer, J. Vacanti (Eds.).
285. Francis PJ, et al. Lens biology: development and human cataractogenesis. Trends Genet 1999, 15:191-196.
286. Graw J, et al. A 6-bp deletion in the Crygc gene leading to a nuclear and radial cataract in the mouse. Invest Ophthalmol Vis Science 2002, 43:236-240.
287. Graw J Cataract mutations and lens development. Prog Retinal Eye Res 1999, 235-267.
288. Haider G, Callaerts P, Gehring WJ Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science 1995, 267:1788-1792.
289. Harding JJ Lens. Biochemistry of the Eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
290. He W, Li S Congenital cataracts: gene mapping. Hum Genet 2000, 106:1-13.
291. Klopp N, et al. Three murine cataract mutants (Cat2) are defective in different Γ-crystallin genes. Genomics 1998, 52:152-158.
292. Korolkovas A, Burckhalter JH Essentials of Medicinal Chemistry 1976, Wiley and Sons, New York.
293. Lodish H, et al. Molecular Cell Biology 2000, WH Freeman, New York.
294. Mathews CK, van Holde KE Biochemistry 1990, Benjamin/Cummings, Redwood City, CA.
295. Nakamura M, et al. Alteration of a developmentally regulated, heat-stable polypeptide in the lens of the Philly mouse. J Biol Chem 1988, 263:19218-19221.
296. Ngo JT, et al. Assignment of the α-B-crystallin gene to human chromosome 11. Genomics 1989, 5:665-669.
297. Ogawa T, Okazaki T Discontinuous DNA replication. Annu Rev Biochem 1980, 49:421-457.
298. Piatigorsky J Lens crystallins and their genes: diversity and tissue-specific expression. FASEB J 1989, 3:1933-1940.
299. Piatigorsky J, Wistow G The recruitment of crystallins: new functions precede gene duplication. Science 1991, 252:1078-1079.
300. Pitts DG A position paper on ultraviolet radiation. Hazards of Light 1986, Pergamon Press, New York. J. Cronly-Dillon, E.S. Rosen, J. Marshall (Eds.).
301. Pitts DG, et al. Damage and recovery in the UV exposed cornea. Hazards of Light 1986, Pergamon Press, New York. J. Cronly-Dillon, E.S. Rosen, J. Marshall (Eds.).
302. Quax-Jenken Y, et al. Complete structure of the αB crystallin gene: conservation of the exon-intron distribution in the two non-linked alpha crystallin genes. Proc Natl Acad Sci USA 1985, 82:5819-5823.
303. Rapp LM, Jose JG, Pitts DG DNA repair synthesis in the rat retina following in vivo exposure to 300 nm radiation. Invest Ophthalmol Vis Sci 1985, 26:384-388.
304. Reddy VN, et al. The effect of aqueous humor ascorbate on ultraviolet-B-induced DNA damage in lens epithelium. Invest Ophthalmol Vis Sci 1998, 39:344-350.
305. Ren Z, et al. A 5-base insertion in the gammaC-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract. Hum Genet 2000, 106:531-537.
306. Roizman B Herpesviridae. Fields Virology 1996, Vol 2. Williams and Wilkins, Philadelphia. 3 rd ed.. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
307. Roizman B, Sears AE Herpes simplex viruses and their replication. Fields Virology 1996, Vol 2. Williams and Wilkins, Philadelphia. 3 rd ed.. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
308. Singh NP, et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988, 175:184-191.
309. Thompson RL, Sawtell NM Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol 2001, 75:6660-6675.
310. Vaughan D, Asbury T General Ophthalmology 1980, Lange Medical, Los Altos, CA.
311. Voet D, Voet JG Biochemistry 1995, Wiley and Sons, New York. 2 nd ed.
312. Watson JD, Crick FHC Molecular structure of nucleic acids. Nature 1953, 171:737-738.
313. Wells R, et al. The chemistry and biology of unusual DNA structures adopted by oligopurine-oligopyrimidine sequences. FASEB J 1988, 2:2939-2949.
314. White JB, Taylor RE, Pittler SJ Reproducible high efficiency gene transfer into Y79 retinoblastoma cells using adenofection. J Neurosci Meth 2001, 106:1-7.
315. Zheng X, et al. HSV-1 migration in latently infected and naïve rabbits after penetrating keratoplasty. Invest Ophthalmol Vis Science 1999, 40:2490-2497.
316. Zigler JS Animal models for the study of maturity-onset and hereditary cataract. Exp Eye Res 1990, 50:651-657.
317. Berson EL Electrical phenomena in the retina. Adler's Physiology of the Eye 1992, Mosby, St. Louis. ed 9. W.M. Hart (Ed.).
318. Catterall WA, et al. Structure and modulation of voltage-sensitive sodium and calcium channels. Biology and Medicine of Signal Transduction 1990, Raven Press, New York. Y. Nishizuka (Ed.).
319. Ehinger B, Dowling JE Retinal neurocircuitry and transmission. Handbook of Chemical Neuroanatomy 1987, 5. Elsevier, New York. A. Bjørklund, T. Høkfelt, L.W. Swanson (Eds.).
320. Euler T, Masland RH Light-evoked responses of bipolar cells in a mammalian retina. J Neurophysiol 2000, 83:1817-1829.
321. Harnois C, DiPaola T Decreased dopamine in the retina of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990, 31:2473-2475.
322. 2- adrenoceptors. Trends Pharm Sci 1991, 12:62-67.
323. Hille B, Catterall WA Electrical excitability and ionic channels. Basic Neurochemistry 1999, Lippincott-Raven, Philadelphia. ed 6. G.J. Siegel (Ed.).
324. Hoffman BB Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. Goodman and Gilman's The Pharmacological Basis of Therapeutics 2001, McGraw-Hill, New York. J.G. Hardman, L.E. Limbird (Eds.).
325. Hulme EC, Kurtenbach E, Curtis CAM Muscarinic acetylcholine receptors: structure and function. Biochemical Soc Trans 1991, 19:133-137.
326. Hunt LA, Sadun AA, Bassi CJ Review of the visual system in Parkinson's disease. Optom Vis Science 1995, 72:92-99.
327. Kandel ER, Schwartz JH, Jessell TM Principles of Neural Science 2000, McGraw-Hill, New York. ed 4.
328. Kuhar MJ, Couceyro PR, Lambert PD Catecholamines. Basic Neurochemistry 1999, Lippincott-Raven, Philadelphia. ed 6. G.J. Siegel (Ed.).
329. Masland RH The fundamental plan of the retina. Nat Neurosci 2001, 4:877-886.
330. Mathews CK, van Holde KE Biochemistry 1990, Benjamin/Cummings Publishing, Redwood City, CA.
331. Morell P, Quarles RH Myelin formation, structure and biochemistry. Basic Neurochemistry 1999, Lippincott-Raven, Philadelphia. ed 6. G.J. Siegel (Ed.).
332. Morgans CW Presynaptic proteins of ribbon synapses in the retina. Micros Res Technique 2000, 50:141-150.
333. Harper's Biochemistry 2000, Appleton and Lange, Stamford, CT. ed 25. R.K. Murray (Ed.).
334. Nguyen-Legros J, Versaux-Botteri C, Vernier P Dopamine receptor localization in the mammalian retina. Mol Neurobiol 1999, 19:181-204.
335. Nicoll RA, Malenka RC, Kauer JA Functional comparison of neuro-transmitter receptor subtypes in mammalian central nervous system. Physiol Rev 1990, 70:513-565.
336. Oyster CW The Human Eye. Structure and Function 1999, Sinauer, Sunderland, MA.
337. Schmitz F, Konigstorfer A, Siidhof TC RIBEYE, a component of synap-tic ribbons: a protein's journey through evolution provides insight into synaptic ribbon function. Neuron 2000, 28:857-872.
338. Stryer L Biochemistry 1988, WH Freeman, New York. ed 3.
339. Taylor P, Brown JH Acetylcholine. Basic Neurochemistry 1999, Lippincott-Raven, Philadelphia. ed 6. G.J. Siegel (Ed.).
340. Taylor WR, Morgans C Localization and properties of voltage-gated calcium channels in cone photoreceptors of Tupaia belangeri. Vis Neurosci 1998, 15:541-552.
341. Vigh J, Banvolgyi T, Wilhelm M Amacrine cells of the anuran retina: morphology, chemical neuroanatomy, and physiology. Micros Res Techniques 2000, 50:373-383.
342. Aghayan-Ugurluoglu R, Ball T, Vrtala S, Schweiger C, Kraft D, Valenta R Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombi-nant pollen allergens. J Allergy Clin Immunol 2000, 105:803-813.
343. Aizuss DH, Mondino BJ, Sumner HL, Dethlefs BA The complement system and host defense against. Pseudomonas endophthalmitis. Invest Ophthalmol Vis Science 1985, 26:1262-1266.
344. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD Molecular Biology of the Cell 1989, Garland Publishing, New York. ed 2.
345. Asbell PA, Alcaraz-Micheli LG Bacterial conjunctivitis. The Cornea 1998, ed 2. Butterworth-Heinemann, Boston. H.E. Kaufman, B.A. Barron, M.B. McDonald (Eds.).
346. Babior BM Phagocytes and oxidative stress. Am J Med 2000, 109:33-44.
347. J-F Bach Immunology 1982, Wiley, New York. ed 2.
348. Banchereau J, Rousset F Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol 1992, 52:125-262.
349. Bielory L Allergic and immunologic disorders of the eye. Part I: immunology of the eye. J Allergy Clin Immunol 2000, 106:805-815.
350. Boggiolini M, Wymann MP Turning on the respiratory burst. Trends Biochem Sci 1990, 15:69-72.
351. Bora NA, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Science 1993, 34:3579-3584.
352. Day ED Advanced Immunochemistry 1990, Wiley-Liss, New York. ed 2.
353. Diez-Fraile A, Meyer E, Burvenish C Regulation of adhesion molecules on circulating neutrophils during coliform mastitis and their possible immunomodulation with drugs. Vet Immunol Immunopath 2002, 86:1-10.
354. Ember JA, Jagels MA, Hugli TE Characterization of complement ana-phylatoxins and their biological responses. The Human Complement System in Health and Disease 1999, Marcel Dekker, NY. J.E. Volankis, M.M. Frank (Eds.).
355. Friedlander M Allergy and Immunology of the Eye 1993, Raven Press, New York.
356. Griffin FM Opsonization, phagocytosis and intracellular microbial killing. The Complement System 1988, Springer-Verlag, Berlin. K. Rother, G.O. Till (Eds.).
357. Hay F, Westwood O The generation of diversity. Immunology 1998, Mosby, St. Louis. ed 5. I. Roitt, J. Brostoff, D. Male (Eds.).
358. Lam SKA, Reid KBM Complement 1988, IRL Press, Oxford.
359. Langford MP, Robertson JB, Orilac R Analysis of neutralizing antibodies to enterovirus 70 and Coxsackie A24 variant, levels of immunoglobu-lins and total protein in tears of patients with acute hemorrhagic conjunctivitis. Ocular Immunol Inflamm 1995, 3:249-259.
360. McBride BW, Ward KA Herpes simplex-specific IgG subclass response in herpetic keratitis. J Med Virology 1987, 21:179-189.
361. Morgan BP Complement, Clinical Aspects and Relevance to Disease 1991, Academic Press, London.
362. Nisonoff A Introduction to Molecular Immunology 1985, Sinauer, Sunderland, MA. ed 2.
363. Plummer TH, Hurwitz NY Human plasma carboxypeptidase N. J Biol Chem 1978, 253:3907-3912.
364. Raj PA, Dentino AR Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 2002, 206:9-18.
365. Robin JB, Dugel R, Robin SB Immunologic disorders of the cornea and conjunctiva. The cornea 1998, Butterworth-Heinemann, Boston. H.E. Kaufman, B.A. Barron, M.B. McDonald (Eds.).
366. Roitt I, Brostoff J, Male D Immunology 1998, Mosby, St. Louis. ed 5.
367. Smolin G, O'Connor GR Ocular Immunology 1986, Little, Brown and Co, Boston. ed 2.
368. Weiner OD Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. Curr Opin Cell Biol 2002, 14:196-202.
369. Yalow RS Radioimmunoassay: a probe for the fine structure of biologic systems. Science 1978, 200:1236-1245.
370. Zachau HG Immunoglobulin light-chain genes of the k type in man and mouse. Immunoglobulin Genes 1989, Academic Press, New York. T. Jonjio, F.W. Alt, T.H. Rabbits (Eds.).
371. Barber AJ, Makamura M, Wolpert EB, Reiter CEN, Seigel GM, Antonetti DA, Gardner TW Insulins rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem 2001, 276:32814-32821.
372. Bishop PN Structural macromolecules and supramolecular organization of the vitreous gel. Progress Ret Eye Res 2000, 19:323-344.
373. Bishop PN, McLeod D, Reardon A The role of glycosaminoglycans in the structural organization of mammalian vitreous. Invest Ophthalmol Vis Sci 1999, 40:2173-2178.
374. Cameron R, Feuer G Incidence of apoptosis and its pathological and biochemical manifestations. Apoptosis and its modulation by drugs 2000, Berlin, Springer. R. Cameron, G. Feuer (Eds.).
375. Crowston JG, Chang LH, Constable PH, Daniels JT, Akbar AN, Khaw PT Apoptosis gene expression and death receptor signaling in mito-mysin-C-treated human tenon capsule flbroblasts. Invest Ophthalmo Vis Science 2002, 43:692-699.
376. Debbasch C, P-J Pisella, De Saint Jean M, Rat P, J-M Warnet, Baudouin C Mitochondria activity and glutathione injury in apoptosis induced by unpreserved and preserved β-blockers on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001, 42:2525-2533.
377. Friedman JS, Faucher M, Hiscott P, Biron VL, Malenfant M, Turcotte P, Raymond V, Walter MA Protein localization in the human eye and genetic screen of opticin. Human Mol Genet 2002, 11:1333-1342.
378. Haddix JL, Pfister RR, Muccio DD, Villain M, Sommers CI, Chaddha M, Anantharamaiab GM, Brouillette WJ, DeLucas LJ Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Invest Ophthalmol Vis Sci 1999, 40:2427-2429.
379. Li QJ, Ashraf MF, DeFen S, Green WR, Stark WJ, C-C Chan, O'Brien TP The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol 2001, 119:1597-1604.
380. Mayne R, Brewton RG, Z-X Ren Vitreous body and zonular apparatus. Biochemistry of the eye 1997, Chapman and Hall, London. J.J. Harding (Ed.).
381. Neuberger A, Gottschalk A, Marshall RD, Spiro RG Carbohydrate-peptide linkages in glycoproteins and methods for their elucidation. Glycoproteins 1972, Elsevier, Amsterdam. A. Gottschalk (Ed.).
382. Nishi O, Nishi K, Wada K, Ohmoto Y, Akura J Inhibition of lens epithelial cells by Fas-specific antibody activating Fas-Fas ligand system. Cur Eye Res 2001, 23:192-198.
383. Parish CA, Hashimoto M, Nakanishi M, Dillon J, Sparrow JR Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci USA. 1998, 95:14609-14613.
384. Parrish CM, Chandler JW Corneal trauma. The cornea 1998, Butterworth-Heinemann, Boston. H.E. Kaufman, B.A. Barron, M.B. McDonald (Eds.).
385. Paterson CA, Williams RN, Parker AV Characteristics of polymor-phonuclear leukocyte infiltration into the alkali burned eye and the influence of sodium citrate. Exp Eye Res 1984, 37:701-708.
386. Pfister RR, Haddox JL, Sommers CI, K-W Lam Identification and synthesis of chemotactic tripeptides from alkali-degraded whole cornea. Invest Ophthalmol Vis Sci 1995, 36:1306-1316.
387. Sebag J The Vitreous 1989, Springer-Verlag, New York.
388. Sparrow JR, Cai B Blue light-induced apoptosis of A2E-containing REP: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 2001, 42:1356-1362.
389. Takanosu M, Boyd TC, Le Goff M, Henry SP, Zhang Y, Bishop PN, Mayne R Structure, chromosomal location, and tissue-specific expression of the mouse optician gene. Invest Ophthalmol Vis Sci 2001, 42:2202-2210.
390. Tsen G, Halfter W, Kroger S, Cole GJ Agrin is a heparan sulfate pro-teoglycan. J Biol Chem 1995, 270:3392-3399.
391. Wenzel A, Grimm C, Seeliger MW, Jaissle G, Hafezi F, Kretschmer R, Zrenner E, Reme CE Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci 2001, 42:1653-1659.
392. Whikehart DR, Edwards WC, Pfister RR Sorption of sodium hydroxide by type I collagen and bovine corneas. Cornea 1991, 10:54-58.
393. Wilson SE, W-J Kim Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci 1998, 39:220-226.
394. Wilson SE Stimulus-specific and cell type-specific cascades: emerging principles relating to control of apoptosis in the eye. Exp Eye Res 1999, 69:255-266.
395. Zimmerman KC, Bonzon C, Green DR The machinery of programmed cell death. Pharm Therap 2001, 92:57-70.